Basel is known for its successful global players in Pharma, Agro and Chemicals. The wealth of top-tier companies, universities and academic institutions in such a small region is unparalleled. It creates an optimum climate for world-class research and its translation into successful businesses. This is also reflected in a strong start-up scene. Over the past decades the multinational players have shown that they are able to adapt to the ever-increasing challenges in the market. Basel has seen blue-chip company mergers, accompanied by the transfer of business assets into spin-off companies. This process created a mind-set for change which has positively influenced the local start-up environment. Actelion is one of these former spin-offs th...
For more than two years five Swiss Universities of Applied Sciences have been cooperating in the fie...
Because private foundations have only modest financial resources compared to public and private-sect...
This paper explores start-up creation in biotech through an in-depth analysis of four new ventures l...
The Greater Zurich Area has become a hub for the life sciences industry in recent years, with above-...
Innovation is one of the main driving factors for continuous and healthy economic growth and welfare...
The universities of applied sciences (UAS) provide several values for the society and economy of a c...
Despite its economic and technological importance, the Swiss life sciences sector faces severe chall...
According to the Global Entrepreneurship Monitor 2013, perceived opportunities to start a business i...
For over 50 years, Switzerland has been one of the leading countries driving innovation in biotechno...
The global biotechnology industry rebounded strongly in 2013. Public companies achieved double-digit...
Advances in genomics and proteomics, completion of the human genome, creation of bio banks, new scie...
The Swiss biotech landscape seems to be on a healthy footing: There are many imaginative start-ups, ...
The WA de Vigier Foundation has supported start-up companies with a total of almost CHF 10 million s...
In the space of a decade, the Lake Geneva region has become the Health Valley, a world-class laborat...
ChemCon is a good example of the approximately 300 new companies founded in the BioValley over the p...
For more than two years five Swiss Universities of Applied Sciences have been cooperating in the fie...
Because private foundations have only modest financial resources compared to public and private-sect...
This paper explores start-up creation in biotech through an in-depth analysis of four new ventures l...
The Greater Zurich Area has become a hub for the life sciences industry in recent years, with above-...
Innovation is one of the main driving factors for continuous and healthy economic growth and welfare...
The universities of applied sciences (UAS) provide several values for the society and economy of a c...
Despite its economic and technological importance, the Swiss life sciences sector faces severe chall...
According to the Global Entrepreneurship Monitor 2013, perceived opportunities to start a business i...
For over 50 years, Switzerland has been one of the leading countries driving innovation in biotechno...
The global biotechnology industry rebounded strongly in 2013. Public companies achieved double-digit...
Advances in genomics and proteomics, completion of the human genome, creation of bio banks, new scie...
The Swiss biotech landscape seems to be on a healthy footing: There are many imaginative start-ups, ...
The WA de Vigier Foundation has supported start-up companies with a total of almost CHF 10 million s...
In the space of a decade, the Lake Geneva region has become the Health Valley, a world-class laborat...
ChemCon is a good example of the approximately 300 new companies founded in the BioValley over the p...
For more than two years five Swiss Universities of Applied Sciences have been cooperating in the fie...
Because private foundations have only modest financial resources compared to public and private-sect...
This paper explores start-up creation in biotech through an in-depth analysis of four new ventures l...